U.S. Capitol is seen after the House approved a bill to repeal major parts of Obamacare and replace it with a Republican healthcare plan in Washington, U.S., May 4, 2017. REUTERS/Yuri Gripas U.S. Senate Republicans on Thursday unveiled legislation that would r... More »
Shares of Gilead Sciences Inc are languishing over concerns about the U.S. biotechnology company’s declining hepatitis C drugs and profit outlook, but some value investors sense an opportunity with shares at extremely cheap levels. More »
A man uses an umbrella to guard against snowfall as he walks past the Nasdaq MarketSite in Times Square, Midtown New York March 20, 2015. REUTERS/Adrees Latif Biotech stocks still have room to rise after the election of Donald Trump as U.S. president, which re... More »
NEW YORK Last July, when Federal Reserve Chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked “stretched,” portfolio manager Graham Tanaka saw an opportunity. After a year-long buying spree,... More »
NEW YORK (Reuters) – Several high-ranking bankers have left their jobs at major investment banks in the last 13 months amid a surge in U.S. healthcare deal activity to seek better compensation at boutique investment banks as well as to participate in the growt... More »
